Prices of 18 new drug formulations are capped in IndiaBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6006 (Published 09 November 2015) Cite this as: BMJ 2015;351:h6006
- Cheryl Travasso
The National Pharmaceutical Pricing Authority of India has capped the prices of 18 new drug formulations, including an intrauterine contraceptive device, antibiotics, painkillers, and drugs for diabetes and hypertension.
The prices have been capped under the Drugs Price Control Order (DPCO) 2013, which establishes a market based pricing mechanism to control the costs of drugs in India.
Sharmila Mary Joseph, member …